Back to
BNP PARIBAS FINANCIAL MARKETS
RETAShowing 0 of 20 quarters
Position history for
BNP PARIBAS FINANCIAL MARKETS's holdings in REATA PHARMACEUTICALS INC-A
As of its Q2 2023 13F, BNP Paribas Financial Markets held 56,365 shares of RETA (Reata Pharmaceuticals), worth $5.7M. BNP Paribas Financial Markets' 13F filings listed RETA from Q4 2018 to Q2 2023, 19 quarterly filings.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of RETA: WELLINGTON MANAGEMENT GROUP LLP